These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms. MacDougall G, Anderton RS, Edwards AB, Knuckey NW, Meloni BP. J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326 [Abstract] [Full Text] [Related]
4. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats. Meloni BP, Milani D, Cross JL, Clark VW, Edwards AB, Anderton RS, Blacker DJ, Knuckey NW. Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591 [Abstract] [Full Text] [Related]
5. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures. Meloni BP, Craig AJ, Milech N, Hopkins RM, Watt PM, Knuckey NW. Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248 [Abstract] [Full Text] [Related]
6. Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model. Edwards AB, Anderton RS, Knuckey NW, Meloni BP. Mol Cell Biochem; 2017 Feb; 426(1-2):75-85. PubMed ID: 27844251 [Abstract] [Full Text] [Related]
7. In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection. MacDougall G, Anderton RS, Ouliel E, Gao J, Redmond SL, Knuckey NW, Meloni BP. Mol Cell Biochem; 2020 Jan; 464(1-2):27-38. PubMed ID: 31679100 [Abstract] [Full Text] [Related]
8. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model. Milani D, Clark VW, Cross JL, Anderton RS, Knuckey NW, Meloni BP. BMC Neurosci; 2016 May 03; 17(1):19. PubMed ID: 27142074 [Abstract] [Full Text] [Related]
9. Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs). Edwards AB, Anderton RS, Knuckey NW, Meloni BP. Brain Sci; 2018 Aug 07; 8(8):. PubMed ID: 30087289 [Abstract] [Full Text] [Related]
10. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H, Futaki S. Acc Chem Res; 2012 Jul 17; 45(7):1132-9. PubMed ID: 22208383 [Abstract] [Full Text] [Related]
11. Interaction of Arginine-Rich Cell-Penetrating Peptides with an Artificial Neuronal Membrane. Mucha P, Sikorska E, Rekowski P, Ruczyński J. Cells; 2022 May 13; 11(10):. PubMed ID: 35626677 [Abstract] [Full Text] [Related]
12. Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor. Vaslin A, Naegele-Tollardo S, Puyal J, Clarke PG. J Neurochem; 2011 Dec 13; 119(6):1243-52. PubMed ID: 22004371 [Abstract] [Full Text] [Related]
13. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization. Futaki S, Nakase I. Acc Chem Res; 2017 Oct 17; 50(10):2449-2456. PubMed ID: 28910080 [Abstract] [Full Text] [Related]
14. Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function. MacDougall G, Anderton RS, Trimble A, Mastaglia FL, Knuckey NW, Meloni BP. Molecules; 2020 Jun 29; 25(13):. PubMed ID: 32610439 [Abstract] [Full Text] [Related]
15. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies. Milani D, Bakeberg MC, Cross JL, Clark VW, Anderton RS, Blacker DJ, Knuckey NW, Meloni BP. PLoS One; 2018 Jun 29; 13(3):e0193884. PubMed ID: 29513757 [Abstract] [Full Text] [Related]
16. PTD4 Peptide Increases Neural Viability in an In Vitro Model of Acute Ischemic Stroke. Mazuryk J, Puchalska I, Koziński K, Ślusarz MJ, Ruczyński J, Rekowski P, Rogujski P, Płatek R, Wiśniewska MB, Piotrowski A, Janus Ł, Skowron PM, Pikuła M, Sachadyn P, Rodziewicz-Motowidło S, Czupryn A, Mucha P. Int J Mol Sci; 2021 Jun 04; 22(11):. PubMed ID: 34200045 [Abstract] [Full Text] [Related]
17. Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides. Kawaguchi Y, Takeuchi T, Kuwata K, Chiba J, Hatanaka Y, Nakase I, Futaki S. Bioconjug Chem; 2016 Apr 20; 27(4):1119-30. PubMed ID: 27019270 [Abstract] [Full Text] [Related]
18. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides. Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP. Eur J Pharm Biopharm; 2015 Jan 20; 89():93-106. PubMed ID: 25459448 [Abstract] [Full Text] [Related]
19. Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action. Meloni BP, Mastaglia FL, Knuckey NW. Front Neurol; 2020 Jan 20; 11():108. PubMed ID: 32158425 [Abstract] [Full Text] [Related]
20. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat. Edwards AB, Cross JL, Anderton RS, Knuckey NW, Meloni BP. Mol Brain; 2018 Feb 09; 11(1):8. PubMed ID: 29426351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]